Aminoglycoside Dosing Based on PK/PD Characteristics
1 clinical trials · Condition
◉ Watch Aminoglycoside Dosing Based on PK/PD Characteristics
| Record | Firm | Date |
|---|---|---|
| Adjustment of Aminoglycoside Dosing Based on Peak Serum Concentration and Bacterial Minimal Inhibitory Concentration (NCT05618457) | Hadassah Medical Organization | 2021-12-01 |
Track Aminoglycoside Dosing Based on PK/PD Characteristics automatically
Every clearance here is in the API, with alerts when new ones post.